Molly Henderson has an estimated net worth of $2.8 Million. This is based on reported shares across multiple companies, which include Phathom Pharmaceuticals, Inc., Lion Biotechnologies, Inc., UroGen Pharma Ltd., Advaxis, Inc., and VirtualScopics, Inc..

2022 was Molly Henderson's most active year for acquiring shares with 8 total transactions. Molly Henderson's most active month to acquire stocks was the month of December. 2023 was Molly Henderson's most active year for disposing of shares, totalling 7 transactions. Molly Henderson's most active month to dispose stocks was the month of October. 2021 saw Molly Henderson paying a total of $39,625.00 for 30,500 shares, this is the most they've acquired in one year. In 2023 Molly Henderson cashed out on 24,160 shares for a total of $218,142.44, their largest year based on trade value.